Matija Snuderl MD

Matija Snuderl first decided to become a doctor, He knew he wanted to be a cardiac surgeon. But once he started medical school, He developed a passion for analyzing disease, specifically cancer. This led to a specialization in neuropathology, the study of nervous system diseases. As a neuropathologist at NYU Langone, He diagnoses brain tumors and other brain diseases in children and adults. As director of molecular pathology, He oversees molecular and genomic profiling, a laboratory method that allows our team to accurately diagnose all types of brain tumors.

Matija Snuderl believes that knowledge is our strength. The more know about cancer, the better we can treat it. At Perlmutter Cancer Center, He collaborates with several medical specialists, including Dr. Diane M. Simeone, Dr. Kwok-Kin Wong, Dr. Harvey I. Pass, Dr. Arjun V. Balar, and Dr. Erik P. Sulman, and Dr. Sylvia Adams. His clinical research focuses on identifying novel biomarkers for diagnosis and therapy. His laboratory at NYU Langone studies cancer genetics and epigenetics and examines the molecular differences between tumors at the cellular level.

Matija Snuderl's team discovered several novel molecularly defined subtypes of brain tumors and contributed to the development of DNA methylation-based classification of brain tumors, an approach that uses machine learning and epigenetic signatures to more effectively diagnose brain tumors. His laboratory is the first in the United States to provide this test to people with brain tumors. He is a member of several professional societies, including the American Association for the Advancement of Science and the American Association of Neuropathologists. He also received the Lucien Rubinstein Award for his research in neuro-oncology.